4.7 Article

Postoperative Complications and Mortality Following Colectomy for Ulcerative Colitis

期刊

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
卷 9, 期 11, 页码 972-980

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2011.07.016

关键词

Inflammatory Bowel Disease; IBD; Therapy; Surgical Complications; Population Based

资金

  1. Merck
  2. Schering-Plough
  3. Abbott Laboratories
  4. Elan Pharmaceuticals
  5. Procter and Gamble
  6. Bristol Meyers Squibb
  7. Millennium Pharmaceuticals
  8. Ferring
  9. Axcan
  10. Jansen
  11. Canadian Institute of Health Research
  12. Alberta Heritage Foundation for Medical Research
  13. Gastroenterological Association Foundation
  14. M.S.I. Foundation
  15. Alberta IBD Consortium

向作者/读者索取更多资源

BACKGROUND & AIMS: Complications after colectomy for ulcerative colitis (UC) have not been well characterized in large, population-based studies. We characterized postoperative in-hospital complications, stratified them by severity, and assessed independent clinical predictors, including use of immunosuppressants. METHODS: We performed population-based surveillance using administrative databases to identify all adults (>= 18 y) who had an International Classification of Diseases-9th/10th revisions code for UC and a colectomy from 1996 to 2009. All medical charts were reviewed. The primary outcome was severe postoperative complications, including in-hospital mortality. Logistic regression was used to assess predictors of complications after colectomy and then restricted to patients undergoing emergent or elective surgeries. RESULTS: Of the 666 UC patients who underwent a colectomy, a postoperative complication occurred in 27.0% and the mortality rate was 1.5%. Independent predictors of postoperative complications were age (for patients >64 vs 18 -34 y: odds ratio [OR], 1.95; 95% confidence interval [CI], 1.07-3.54), comorbidities (>2 vs none: OR, 1.89; 95% CI, 1.06 3.37), and admission status (emergent vs elective colectomy: OR, 1.62; 95% CI, 1.14-2.30). Significant risk factors for an emergent colectomy included time from admission to colectomy (>14 vs 3-14 d: OR, 3.32; 95% CI, 1.62-6.80) and a preoperative complication (>= 1 vs 0: OR, 3.04; 95% CI, 1.33-6.91). A prescription of immunosuppressants before colectomies did not increase the risk for postoperative complications. CONCLUSIONS: Postoperative complications frequently occur after colectomy for UC, predominantly among elderly patients with multiple comorbidities. Patients who were admitted to the hospital under emergency conditions and did not respond to medical treatment had worse outcomes when surgery was performed 14 or more days after admission.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据